Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Nerve Blocks in Breast Reconstruction
NCT04860843Recruiting
- Sponsor
- University of British Columbia
- Start
- May 2021
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of British Columbia. Primary endpoints: Rate of participant recruitment at 1 year, Rate of successful nerve blocks at 1 year and 2 more. Started May 2021; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04860843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860843.